Kamada Investor Relations Material
Latest events
Q2 2024
Kamada
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Kamada Ltd
Access all reports
Kamada Ltd. is a globall biopharmaceutical company that focuses on the development, production, and marketing of plasma-derived protein therapeutics. The company is known for its specialty in products designed for rare diseases, operating across two main segments: Proprietary Products and Distribution. Kamada's diverse product range includes treatments for conditions such as immune thrombocytopenic purpura, hepatitis B, varicella, and Alpha-1 Antitrypsin Deficiency (AATD), among others. Additionally, it has developed specific immunoglobulins for various applications, including rabies and diseases caused by Rh-negative in the fetus. Kamada markets its products through strategic partnerships and distributors internationally, including collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. The company prides itself on its industry-leading manufacturing capabilities and a robust development pipeline aimed at addressing unmet medical needs. Kamada Ltd. is headquartered in Rehovot, Israel, and its shares are listed on the Nasdaq.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
KMDA
Country
🇺🇸 United States